跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
Solifenacin APOTEX solifenacin succinate 5 mg film coated tablets blister
Approved
STANDARD
Solifenacin APOTEX solifenacin succinate 5 mg film coated tablets blister
Arrotex Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
3f532f85e648aa9c
Company
Arrotex Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
3f532f85e648aa9c
Product Name
Solifenacin APOTEX solifenacin succinate 5 mg film coated tablets blister
Artg Id
218403
Artg Name
Solifenacin APOTEX solifenacin succinate 5 mg film coated tablets blister
Sponsor
Arrotex Pharmaceuticals Pty Ltd
Company Detail Path
/organization/arrotex-pharmaceuticals-pty-ltd
Artg Date
2016-01-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
3f532f85e648aa9c
Type
Standard
Back to TGA Approvals
Solifenacin APOTEX solifenacin succinate 5 mg film coated tablets blister - TGA Drug Approval Details
